Tetragon's passive stake at 5.3% is unchanged — no new buying or selling signal. Monitor for any future conversion to a 13D filing, which would indicate activist intent. The call option component (500,000 ADSs) adds modest upside exposure but does not change the passive characterization.
Price Chart
Executive Summary
Tetragon Financial Management LP and related entities filed an amended Schedule 13G disclosing a 5.3% passive stake in Silence Therapeutics plc, representing 9,878,565 ordinary shares (held as ADSs and call options). The filing confirms a passive position with no activist intent, and the stake is unchanged from the initial filing on the same date.
Key Financial Metrics
Key Facts
- Tetragon Financial Group Limited and related entities hold 9,878,565 ordinary shares (5.3% of outstanding) in Silence Therapeutics plc.
- The stake is represented by 3,292,855 ADSs (each ADS = 3 ordinary shares), including 1,500,000 shares underlying call options.
- The filing is an amendment to the initial Schedule 13G filed on October 13, 2026, and restates the same position.
- The percentage is based on 186,461,401 shares outstanding as reported in the company's August 2026 prospectus and press release.
- The filers certify passive intent under Rule 13d-1(c), disclaiming any control purpose.
Financial Impact
No financial impact — the stake is unchanged from the initial filing.
Risk Factors
- Tetragon could convert to an activist 13D filer, though the current filing explicitly disclaims control intent.
- The stake is below the 5% threshold for most passive filings, but the filers have disclosed it voluntarily.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000919574-26-006906 |
| Document: 0000919574-26-006906-index.html | 0000919574-26-006906 |
| Document: 0000919574-26-006906.txt | 0000919574-26-006906 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 7d ago | DEFA14A | $19.61 $19.67 | ▲ +0.31% | ▼ −0.22% | $19.78 (+0.87%) |
Oct 19, 2026 7d ago | DEFA14A | $19.58 $19.61 | ▲ +0.15% | ▼ −0.18% | $19.78 (+1.02%) |
Oct 19, 2026 7d ago | 8-K | $19.58 $19.61 | ▲ +0.15% | ▼ −0.18% | $19.78 (+1.02%) |
Oct 13, 2026 13d ago | SC 13G/A | $8.98 $9.35 | ▲ +4.12% | ▲ +3.84% | $19.78 (+120.27%) |
Oct 13, 2026 13d ago | SC 13G | $8.98 $9.35 | ▲ +4.12% | ▲ +3.84% | $19.78 (+120.27%) |
Aug 10, 2026 11w ago | 424B5 | $14.72 $13.58 | ▲ +7.74% | ▲ +8.00% | $19.78 (−34.38%) |
Aug 10, 2026 11w ago | 8-K | $15.43 $14.72 | ▼ −4.60% | ▼ −4.28% | $19.78 (+28.19%) |
Aug 10, 2026 11w ago | 8-K | $15.43 $14.72 | ▼ −4.60% | ▼ −4.28% | $19.78 (+28.19%) |
Jun 23, 2026 17w ago | 8-K | $9.16 $10.00 | ▲ +9.17% | ▲ +9.03% | $19.78 (+115.94%) |
Mar 5, 2026 33w ago | 8-K | $5.50 $6.23 | ▲ +13.27% | ▲ +14.59% | $19.78 (+259.64%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers